Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: Results from a prostate cancer screening cohort of 1490 men

International Journal of Urology

Volumn 16, Issue 1, 2009, Pages 91-95

  Capitanio, Umberto ^a,b   Perrotte, Paul ^c   Hutterer, Georg C ^b   Suardi, Nazareno ^a,b   Jeldres, Claudio ^b,c   Shariat, Shahrokh F ^b   Duclos, Alain ^c   Arjane, Philippe ^c   Montorsi, Francesco ^a   Karakiewicz, Pierre I ^b,c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Body mass index; Prostate cancer; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER CLASSIFICATION; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; CANADA; COHORT STUDIES; HUMANS; LINEAR MODELS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 58149191583     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02192.x     Document Type: Article

References (29)

1. Freedland SJ, Aronson WJ, Kane CJ et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J. Clin. Oncol. 2004 22 : 446 53.
2. Buschemeyer WC, 3rd., Freedland SJ. Obesity and prostate cancer: epidemiology and clinical implications. Eur. Urol. 2007 52 : 331 43.
3. Amling CL, Riffenburgh RH, Sun L et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J. Clin. Oncol. 2004 22 : 439 45.
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003 348 : 1625 38.
5. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991 2 : 85 94.
6. Whittemore AS, Kolonel LN, Wu AH et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J. Natl. Cancer Inst. 1995 87 : 652 61.
7. Raaijmakers R, de Vries SH, Blijenberg BG et al. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/mL. Eur. Urol. 2007 52 : 1358 64.
8. Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml. Eur. Urol. 2006 49 : 293 302.
9. Bjartell A. PSA and prostate cancer screening: the challenge of the new millennium. Eur. Urol. 2007 52 : 1284 6.
10. Capitanio U, Scattoni V, Freschi M, et al. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur. Urol. 2008.
11. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended 10-core biopsy nomogram. Eur. Urol. 2007 52 : 436 45.
12. Baillargeon J, Pollock BH, Kristal AR et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005 103 : 1092 5.
13. Fontaine KR, Heo M, Allison DB. Obesity and prostate cancer screening in the USA. Public Health 2005 119 : 694 8.
14. Luo W, Morrison H, de Groh M et al. The burden of adult obesity in Canada. Chronic Dis. Can. 2007 27 : 135 44.
15. Hutterer G, Perrotte P, Gallina A et al. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur. J. Cancer 2007 43 : 1180 7.
16. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech. Rep. Ser. 1995 854 : 1 452.
17. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men. Br. J. Cancer 2003 89 : 1237 42.
18. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006 295 : 1549 55.
19. Zeegers MP, Dirx MJ, van den Brandt PA. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up. Cancer Epidemiol. Biomarkers Prev. 2005 14 : 1490 5.
20. Jonsson F, Wolk A, Pedersen NL et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int. J. Cancer 2003 106 : 594 9.
21. Andersson SO, Wolk A, Bergstrom R et al. Body size and prostate cancer: a 20-year follow-up study among 135 006 Swedish construction workers. J. Natl. Cancer Inst. 1997 89 : 385 9.
22. Kobayashi T, Mitsumori K, Nishizawa K, Kawahara T, Ogura K, Ide Y. Association between body mass index and prostate cancer detection rates in Japanese urologic patients. Urology 2005 66 : 130 4.
23. Ahn JO, Ku JH. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men. Urology 2006 68 : 570 4.
24. Fowke JH, Signorello LB, Chang SS et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 2006 107 : 2361 7.
25. Gallina A, Karakiewicz PI, Hutterer GC et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int. J. Cancer 2007 121 : 791 5.
26. Thompson IM, Leach R, Troyer D, Pollock B, Naylor S, Higgins B. Relationship of body mass index and prostate specific antigen in a population-based study. Urol. Oncol. 2004 22 : 127 31.
27. Freedland SJ, Platz EA, Presti JC et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J. Urol. 2006 175 : 500 4, discussion 504.
28. Cox BD, Whichelow M. Ratio of waist circumference to height is better predictor of death than body mass index. BMJ 1996 313 : 1487.
29. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomarkers Prev. 1999 8 : 25 34.